Navigation Links
A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients

Final Results from Exploratory Phase IIa Clinical Trial in Type 2 Diabetes Patients Announced

TORONTO, June 28, 2007 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition") , today announces the results from its exploratory Phase IIa clinical trial indicating that 4-weeks of daily treatments with gastrin-based therapy, E1-I.N.T.(TM), showed sustained reductions in blood glucose control parameters, including haemoglobinA1C (HbA1c), for 6 months post-treatment. The type 2 diabetes patients enrolled in this study were using metformin with/without thiazolidinediones (TZD). Transition will host a conference call to discuss these data at 5:00 pm EST on Thursday June 28th, 2007.

"These data are very encouraging and show the potential of a regenerative therapy in diabetes," said Sherwyn Schwartz, MD, a noted diabetes researcher and the Director of the Diabetes & Glandular Disease Research Associates in San Antonio, Texas who was the lead investigator of the study.

"Achieving sustained improvements in glucose control for many months post-treatment following a 4-week therapy is unprecedented in type 2 diabetes. The improvements in HbA1c correlated with changes in multiple other clinical parameters suggesting that gastrin-based therapies, and specifically E1-I.N.T.(TM), have the potential to re-engage the body's natural mechanism to regulate glucose," said Dr. Tony Cruz, Chairman and Chief Executive Officer of Transition. "The immediate goal is to optimize the dosing regimen in a larger phase II study".

Key Efficacy Findings:

As in Transition's press release on March 5th, 2007, analysis of efficacy parameters was performed on type 2 diabetes patients with HbA1c levels of equal to or greater than 7% prior to treatment.

In the E1-I.N.T.(TM) treated group of patients, the mean HbA1c level was reduced by 0.94% to 1.21% vs. baseline levels in months 2 to 6 post-treatment. Mor
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
11. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
Post Your Comments:
(Date:5/17/2013)... 2013  Atossa Genetics, Inc. (NASDAQ: ATOS ), ... Guse , Chief Financial Officer & General Counsel, will ... Thursday, May 30, 2013, in New York City ... The Company,s presentation is scheduled to begin at 3:30 p.m. ... access the webcast, go to www.atossagenetics.com . ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... Inc. (ERT), (Nasdaq: ERT ) a ... devices to biopharmaceutical and healthcare organizations and the market ... services in drug development, announced today results for ... otherwise noted, all comparative numbers refer to changes ...
... MOUNTAIN VIEW, Calif., Oct. 27, 2011 IRIDEX Corporation (NASDAQ: ... quarter 2011 financial results after the market closes on ... the Company will host a conference call with the investment community ... Thursday, November 3, 2011 to discuss the results ...
Cached Medicine Technology:ERT Reports Third Quarter 2011 Operating Results 2ERT Reports Third Quarter 2011 Operating Results 3ERT Reports Third Quarter 2011 Operating Results 4ERT Reports Third Quarter 2011 Operating Results 5ERT Reports Third Quarter 2011 Operating Results 6ERT Reports Third Quarter 2011 Operating Results 7ERT Reports Third Quarter 2011 Operating Results 8ERT Reports Third Quarter 2011 Operating Results 9ERT Reports Third Quarter 2011 Operating Results 10ERT Reports Third Quarter 2011 Operating Results 11ERT Reports Third Quarter 2011 Operating Results 12ERT Reports Third Quarter 2011 Operating Results 13
(Date:5/19/2013)... Grinding your teeth at night can ... annoying your spouse. At the same time, according to ... and Teeth Grinding Could Be a Sign of Sleep ... be hard to prevent. Apparently, Obstructive Sleep Disorder (OSD) ... its symptoms is a habit of teeth grinding along ...
(Date:5/19/2013)... 2013 Fat Burning Furnace developed by ... provides people with fat burning diet plans, ... Fat Burning Furnace package, people will receive the Fat ... download quickly. The Fat Burning Furnace manual includes fat ... lean muscle mass. In addition, this book covers step-by-step ...
(Date:5/19/2013)... WA (PRWEB) May 19, 2013 The Fat ... weight loss secrets that help people get in ... gender, and body shape. The program also is a natural ... diet plans. Besides, the author of this fat loss diet ... transformation program, which can help people keep body fat off ...
(Date:5/19/2013)... 2013 Passages Malibu, the leading non-12 ... announced this week the launch of a “Sobriety, Health, ... media channels. “We are always looking for new ... to get feedback regarding sobriety, what’s working for people, ... of the Passages Addiction Treatment Centers located ...
(Date:5/19/2013)... Minor fender benders and serious car accidents are ... the accident to respond appropriately to the situation. ... data from 2010, accidents, including car accidents, are the ... in 2005, automobile accident-related deaths cost over ... million drivers and passengers receive treatment in an emergency ...
Breaking Medicine News(10 mins):Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... the air, indeed! Today, it has been revealed that deaths ... past decade// and we owe this development to better ... treatment measures. ,The data enabled by the government ... deaths since 1966 for those below 75 years of age. ...
... women with higher levels of Vitamin-E in their blood are ... ,Theresa O. Scholl and colleagues at the University of ... women and measured the plasma concentrations of alpha-tocopherol-one, a form ... pregnancy. ,They found the women who had ...
... Delhi Chief Minister Sheila Dikshit today inaugurated a new 120-bed ... at the Tihar Jail//, one of Asia’s biggest prisons having ... the jail hospital premises, was built at a cost of ... of its kind to be started in any jail in ...
... A team of University of California, San Diego physicists ... of blood vessels// in the brain that makes it ... of the puzzling damage to the brain’s gray matter ... ,In the study, published this week in the ...
... of us think of chromium as the shiny metal in ... the metal plays a crucial role in human health//, reports ... In rats, chromium deficiency leads to high cholesterol levels. In ... information, it’s too early to recommend chromium supplements for cholesterol. ...
... it’s our most vital organ, surprisingly little is ... makes it harder to uncover what’s gone awry ... brain-associated disorders, and ultimately, it often leaves physicians ... as Alzheimer’s and Parkinson’s disease, schizophrenia, attention deficit ...
Cached Medicine News:Health News:Bottleneck in Blood Supply Makes Brain Vulnerable to Strokes 2Health News:Bottleneck in Blood Supply Makes Brain Vulnerable to Strokes 3Health News:Chromium May Help Diabetes, Cholesterol, and Heart Disease 2Health News:Researchers Looking for Genes That Control the Brain 2
... Facilitates grasping and implanting the ... and within the capsular bag without ... mm long jaws are placed in ... handle. Smooth, flat, cross action handle ...
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Puntenney curved forceps, curved, smooth 10 mm platforms....
Hatsis tying forceps, titanium, long thin tying platforms....
Medicine Products: